“It is a lot to digest. And from the point of view of Big Pharma and the government lab, it’s almost unbelievable, ”said Neal Hunter, 59, CEO of EmitBio.
If this device is endorsed to treat mild cases of COVID-19, it would be a treatment option for patients because it could be used at home, in contrast to treatments that are applied in doctors’ offices.
However, one question you have about the company’s approach is how you could prevent the disease from progressing in the lungs where the light does not reach. “What we really need is something to keep people out of the hospital and prevent them from dying, and that’s really a lower respiratory disease process.”
That said, it does suggest that using the EmitBio device could help people who have recently been exposed to someone who has Covid. “The infection starts pretty much in the upper respiratory tract, so maybe that can be a useful thing.”
“I think it’s quite plausible when you just need to do a definitive study,” he explained.
EmitBio is currently working with the FDA on a possible emergency use authorization for your device, Stasko explained, but before you get approval from the regulatory agency, you need to provide more data.